Boltwood Capital Management Eli Lilly & CO Transaction History

Boltwood Capital Management

$319 Million
Q2 2024

A detailed history of Boltwood Capital Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Boltwood Capital Management holds 2,170 shares of LLY stock, worth $1.96 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

2,170

Previous 2,303 5.78%

Holding current value

$1.96 Million

Previous $1.79 Million 9.66%

% of portfolio

0.62%

Previous 0.56%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 08, 2024	SELL	$724.87 - $909.04 $96,407 - $120,902	-133 Reduced 5.78%	2,170 $1.96 Million
Q1 2024 Apr 04, 2024	SELL	$592.2 - $792.28 $213,784 - $286,013	-361 Reduced 13.55%	2,303 $1.79 Million
Q4 2023 Jan 05, 2024	SELL	$525.19 - $619.13 $125,520 - $147,972	-239 Reduced 8.23%	2,664 $1.55 Million
Q3 2023 Oct 10, 2023	SELL	$434.7 - $599.3 $144,755 - $199,566	-333 Reduced 10.29%	2,903 $1.56 Million
Q2 2023 Jul 06, 2023	SELL	$350.74 - $468.98 $117,497 - $157,108	-335 Reduced 9.38%	3,236 $1.52 Million
Q1 2023 Apr 03, 2023	BUY	$310.63 - $364.82 $37,586 - $44,143	121 Added 3.51%	3,571 $1.23 Million
Q4 2022 Jan 06, 2023	SELL	$321.55 - $374.67 $86,175 - $100,411	-268 Reduced 7.21%	3,450 $0
Q3 2022 Oct 04, 2022	SELL	$296.48 - $337.87 $156,244 - $178,057	-527 Reduced 12.41%	3,718 $1.2 Million
Q2 2022 Jul 07, 2022	SELL	$278.73 - $327.27 $598,154 - $702,321	-2,146 Reduced 33.58%	4,245 $1.38 Million
Q1 2022 Apr 20, 2022	SELL	$234.69 - $291.66 $21,122 - $26,249	-90 Reduced 1.39%	6,391 $1.83 Million
Q4 2021 Jan 10, 2022	BUY	$224.85 - $279.04 $4,047 - $5,022	18 Added 0.28%	6,481 $1.79 Million
Q3 2021 Oct 08, 2021	SELL	$221.6 - $272.71 $19,279 - $23,725	-87 Reduced 1.33%	6,463 $1.49 Million
Q2 2021 Jul 06, 2021	SELL	$180.55 - $233.54 $3,611 - $4,670	-20 Reduced 0.3%	6,550 $1.5 Million
Q1 2021 Apr 05, 2021	SELL	$164.32 - $212.72 $101,878 - $131,886	-620 Reduced 8.62%	6,570 $1.23 Million
Q4 2020 Jan 04, 2021	SELL	$130.46 - $172.63 $20,873 - $27,620	-160 Reduced 2.18%	7,190 $1.21 Million
Q3 2020 Oct 05, 2020	BUY	$146.22 - $169.13 $1,462 - $1,691	10 Added 0.14%	7,350 $1.09 Million
Q2 2020 Jul 02, 2020	SELL	$136.42 - $164.18 $3,410 - $4,104	-25 Reduced 0.34%	7,340 $1.21 Million
Q1 2020 Apr 07, 2020	SELL	$119.05 - $147.35 $5,357 - $6,630	-45 Reduced 0.61%	7,365 $1.02 Million
Q4 2019 Jan 07, 2020	BUY	$106.92 - $132.43 $792,277 - $981,306	7,410 New	7,410 $974,000

Others Institutions Holding LLY

# of Institutions

3,865

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $858B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boltwood Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Boltwood Capital Management with notifications on news.

Account

Boltwood Capital Management Eli Lilly & CO Transaction History